Calcium and vitamin D supplementation can improve cholesterol levels in postmenopausal women, lowering the “bad” cholesterol and increasing the “good.”
Calcium and vitamin D supplements can improve cholesterol levels in postmenopausal women, according to a study that was published ahead-of-print in Menopause, the journal of The North American Menopause Society.
- Calcium and vitamin D supplements
can improve
cholesterol levels in postmenopausal women.
- When compared with placebo,
women taking the supplements were more than twice as likely to have vitamin D levels within the normal level recommended by the Institute of Medicine.
- The supplements showed benefit over placebo in both HDL and LDL cholesterol levels.
The study, led by Peter Schnatz, DO, looked at both how a calcium and vitamin D supplement changed cholesterol levels and how it affected blood levels of vitamin D in postmenopausal women.
The placebo-controlled study involved 600 women from the Women’s Health Initiative Cacium/Vitamin D (WHI CaD) trial, according to a news release issued by NAMS that announced the early results. Women were either given a supplement containing 1,000 mg of calcium and 400 IU of vitamin D3 or a placebo. The researchers’ analysis then looked at the relationship between taking supplements and levels of vitamin D and cholesterol in the 600 women.
Those who took the supplement were more than twice as likely to have vitamin D levels of at least 30 ng/mL (the normal level, according to the Institute of Medicine), as were the women who took the placebo. In addition, the researchers found low-density lipoprotein cholesterol levels to be between 4 and 5 points lower among those taking the supplement compared with those taking placebo. Finally, the results indicated that among the supplement users, those with higher levels of vitamin D also had higher levels of high-density lipoprotein cholesterol and lower levels of triglycerides.
The benefits of taking the supplements were especially strong among older women and those who had a low intake of vitamin D and calcium.
Schnatz PF, Jiang X, Vila-Wright S, et al. Calcium/vitamin D supplementation, serum 25-hydroxyvitamin D concentrations, and cholesterol profiles in the Women's Health Initiative calcium/vitamin D randomized trial. Menopause. 2014;doi:10.1097/GME.0000000000000188.
First patient dosed in trial evaluating fezolinetant for VMS in breast cancer patients
August 28th 2024Astellas Pharma has announced the first dose administration of fezolinetant to manage moderate to severe vasomotor symptoms in breast cancer patients using adjuvant endocrine therapy.
Read More
Higher multimorbidity risk reported from reduced reproductive lifespan
August 12th 2024A recent study found that women with a shorter reproductive lifespan had increased odds of multimorbidity compared to those with a longer reproductive lifespan, indicating a need to assess reproductive factors to determine high-risk patients.
Read More